Formidable Asset Management’s BioAtla BCAB Stock Holding History

Formidable Asset Management’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,943	Closed	-$57.4K	–	386
2024 Q4	$57.4K	Sell	1,943 -49	-2%	-$4.11K	0.01%	368
2024 Q3	$175K	Sell	1,992 -97	-5%	-$8.13K	0.03%	351
2024 Q2	$143K	Sell	2,089 -814	-28%	-$96.8K	0.02%	376
2024 Q1	$499K	Sell	2,903 -182	-6%	-$22.6K	0.08%	226
2023 Q4	$379K	Sell	3,085 -171	-5%	-$14.8K	0.08%	200
2023 Q3	$277K	Buy	3,256 +1,437	+79%	+$183K	0.06%	226
2023 Q2	$273K	Hold	1,819	–	–	0.06%	226
2023 Q1	$244K	Buy	1,819 +1,127	+163%	+$203K	0.05%	245
2022 Q4	$286K	Sell	692 -136	-16%	-$56.4K	0.06%	235
2022 Q3	$318K	Sell	828 -614	-43%	-$201K	0.07%	211
2022 Q2	$205K	Buy	+1,442	New	+$229K	0.05%	271

Other funds holding BCAB

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Formidable Asset Management's BCAB Position: Q1 2025 in Review

Formidable Asset Management sold out of BioAtla (BCAB) in Q1 2025, closing a stake of 1,943 shares — an estimated $57.4K sold.

Formidable Asset Management first reported a position in BCAB in Q2 2022 and held it in 11 quarters. The position peaked at $499K in Q1 2024. 41 funds tracked by Wall St. Rank hold BCAB as of Q1 2025.

Formidable Asset Management reported no remaining BioAtla position as of Q1 2025 after selling out during the quarter.
Formidable Asset Management sold 1,943 BioAtla shares in Q1 2025, an estimated $57.4K.
Formidable Asset Management first reported a position in BioAtla in Q2 2022 and held it in 11 quarters.
Formidable Asset Management's BioAtla position peaked at $499K in Q1 2024.
41 funds tracked by Wall St. Rank held BioAtla as of Q1 2025.

Based on Formidable Asset Management's 13F filing for Q1 2025, filed 5 May 2025.